News and Press Releases
Cellular Origins, a TTP Company, appoints Peter Crossley as Chief Operating Officer
Product and technology innovator will build team to further develop and deliver Cellular Origins’ products for cell and gene therapy manufacture at scale 25 January 2024 -- Cambridge, UK --...
Category: BioManufacturing
Posted: January 25, 2024
AES Clean Technology expands senior leadership team with key appointment
18 January 2024 -- Pennsylvania, US -- A leading provider of high-performance cleanroom facilities, AES Clean Technology, has appointed Brian Weed as chief revenue officer (CRO). With 18 years of...
Category: Manufacturing and Packing
Posted: January 18, 2024
Blue Spark Technologies Adds MaryAnne Rizk to Board of Advisors
Cutting-Edge Remote Patient Monitoring Technology Enhances Leadership with the Appointment of Board of Advisors 4 January 2024 -- Ohio, US -- Blue Spark Technologies, a proven innovative digital health technology...
Category: Biotechnology
Posted: January 4, 2024
Broken String Biosciences appoints Gavin Burns as Vice President of Quality and Operations
Experienced quality assurance professional joins team to support ongoing strategic growth plans as the company expands access and capabilities of INDUCE-seq DNA break mapping platform Expansion to leadership team follows...
Category: Biotechnology
Posted: November 22, 2023
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR
Landmark Phase 3 MARIPOSA Study Shows RYBREVANT▼(amivantamab) Plus Lazertinib Resulted in 30% Reduction in Risk of Disease Progression or Death Compared to Osimertinib in Patients with EGFR-Mutated NSCLC
Early data show an overall survival trend favoring the combination of amivantamab and lazertinib compared to osimertinib; consistent results seen in patients with and without brain metastases Late-breaking results from...
Category: Clinical Trials
Posted: October 24, 2023
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
Results from Phase 2 THOR-2 Study Showed Improved Rates of Recurrence-Free Survival in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations Treated with Erdafitinib Versus Chemotherapy
Data from Cohort 1 of the phase 2 THOR-2 study showed oral erdafitinib reduced the risk of disease recurrence or death compared with intravesical standard-of-care chemotherapy 21 October 2023 --...
Category: Clinical Trials
Posted: October 23, 2023
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
European Commission Approves ADCETRIS (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage III Hodgkin Lymphoma in Combination with AVD
· Approval Based on Updated Positive Overall Survival Results from the phase 3 ECHELON-1 Study for Stage III & IV Hodgkin Lymphoma · First Significant Improvement in Overall Survival in Two Decades...
Category: Pharmaceutical
Posted: October 23, 2023
Closed Loop Medicine appoints Konstantinos Vlassis as Chief Technology Officer
Key executive leadership role will oversee design and implementation of technology strategy, engineering resources and infrastructure to deliver corporate objectives 10 October 2023 -- London, UK -- Closed Loop Medicine,...
Category: Biotechnology
Posted: October 10, 2023
Babraham Research Campus Cambridge CB22 3AT United Kingdom
MSD’s WELIREG▼(belzutifan) made available for the treatment of eligible adults with von Hippel-Lindau (VHL) disease in Scotland
Scotland is the first European country to accept belzutifan as a treatment for adult patients with von Hippel-Lindau (VHL) disease who require therapy for VHL-associated renal cell carcinoma (RCC), central...
Category: Pharmaceutical
Posted: October 9, 2023
1 rue Jacques Monod, Site Montesquieu, 33650 Martillac, France
TekniPlex Hires Rahul Goturi as Chief Information Officer
Executive-level move coincides with retirement of longtime CIO Jeff Rishel Goturi brings more than 15 years of CIO experience at global organisations 4 October 2023 -- Ohio, US -- TekniPlex,...
Category: Manufacturing and Packing
Posted: October 4, 2023
Industrielaan 37 B-9320 Erembodegem Belgium Tel: +32 (0)53 650711 VAT 0425.537.515
FUJIFILM Diosynth Biotechnologies President and CEO Lars Petersen appoints Maja Pedersen as Chief Quality Officer
4 October 2023 -- Hillerød, Denmark -- FUJIFILM Diosynth Biotechnologies president and CEO Lars Petersen today announced a new strategic leadership appointment to support the company through its next growth...
Category: Biotechnology
Posted: October 4, 2023
Broken String Biosciences strengthens senior leadership team to accelerate product development and commercialisation
Appointment of Vincent Smith PhD, as chief technology officer and Jessica Rich as VP of Business Development Follows Broken String’s successful $15m Series A fundraising round in September 2023 Will...
Category: Biotechnology
Posted: October 4, 2023
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR
